Study in patients with atopic dermatitis for effects of systemic immunomodulatory treatments on COVID-19 outcomes
Latest Information Update: 01 Feb 2023
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Pharmacodynamics
- Acronyms global SECURE-AD registry
Most Recent Events
- 01 Feb 2023 Results published in the Journal of the European Academy of Dermatology and Venereology
- 31 Jan 2023 New trial record